Daoyan Wei

7.7k total citations · 1 hit paper
75 papers, 6.2k citations indexed

About

Daoyan Wei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Daoyan Wei has authored 75 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 22 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Daoyan Wei's work include Cancer-related gene regulation (19 papers), Kruppel-like factors research (18 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Daoyan Wei is often cited by papers focused on Cancer-related gene regulation (19 papers), Kruppel-like factors research (18 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Daoyan Wei collaborates with scholars based in United States, China and Italy. Daoyan Wei's co-authors include Keping Xie, Suyun Huang, Xiangsheng Zuo, Zhiliang Jia, Xiangdong Le, Yongmin Yan, James C. Yao, Allen C. Gao, Weida Gong and Liwei Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Daoyan Wei

73 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target

2015 492 citations Yongmin Yan, Xiangsheng Zuo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daoyan Wei United States	43	4.3k	2.0k	1.7k	632	629	75	6.2k
Dung‐Fang Lee United States	36	4.9k 1.1×	1.6k 0.8×	1.4k 0.8×	660 1.0×	368 0.6×	87	6.3k
Sophie Vacher France	39	2.6k 0.6×	1.5k 0.7×	1.5k 0.9×	429 0.7×	448 0.7×	142	4.5k
Roger R. Gomis Spain	30	3.4k 0.8×	2.5k 1.2×	1.6k 0.9×	544 0.9×	318 0.5×	67	6.0k
Peng Hou China	41	3.3k 0.8×	1.3k 0.6×	1.1k 0.7×	429 0.7×	571 0.9×	177	5.7k
Youyong Lu China	35	2.8k 0.7×	1.4k 0.7×	1.5k 0.9×	358 0.6×	418 0.7×	122	4.4k
Jinjun Li China	45	4.8k 1.1×	1.7k 0.8×	3.1k 1.9×	520 0.8×	321 0.5×	137	7.0k
Bruce Ruggeri United States	41	3.6k 0.8×	2.8k 1.4×	939 0.6×	711 1.1×	326 0.5×	121	6.8k
Jiong Deng China	30	3.3k 0.8×	2.0k 1.0×	1.2k 0.7×	644 1.0×	372 0.6×	61	4.8k
Masahiro Aoki Japan	31	3.6k 0.8×	1.3k 0.6×	824 0.5×	752 1.2×	274 0.4×	71	4.9k
Deborah A. Altomare United States	37	4.0k 0.9×	1.7k 0.8×	1.0k 0.6×	683 1.1×	336 0.5×	69	6.4k

Countries citing papers authored by Daoyan Wei

Since Specialization

Citations

This map shows the geographic impact of Daoyan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoyan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoyan Wei more than expected).

Fields of papers citing papers by Daoyan Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoyan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoyan Wei. The network helps show where Daoyan Wei may publish in the future.

Co-authorship network of co-authors of Daoyan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Daoyan Wei. A scholar is included among the top collaborators of Daoyan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoyan Wei. Daoyan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fields, Chris, Lorenzo Cohen, Sharmistha Chakraborty, et al.. (2024). Search for Entanglement between Spatially Separated Living Systems: Experiment Design, Results, and Lessons Learned. SHILAP Revista de lepidopterología. 4(2). 168–181. 1 indexed citations

Wei, Daoyan, et al.. (2023). Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 22(6). 693–705. 5 indexed citations

Wei, Daoyan, Liang Wang, Yi Liu, et al.. (2023). Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression. Digestive Diseases and Sciences. 68(7). 3043–3058. 6 indexed citations

Wei, Daoyan, Liang Wang, Xiangsheng Zuo, Anirban Maitra, & Robert S. Bresalier. (2023). A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer. Clinical Cancer Research. 30(4). 655–662. 63 indexed citations

Liu, Yi, Yasunori Deguchi, Daoyan Wei, et al.. (2022). Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nature Communications. 13(1). 2665–2665. 45 indexed citations

Wang, Liang, Zhiliang Jia, Dacheng Xie, et al.. (2020). Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics. Cancer Research. 80(20). 4500–4513. 38 indexed citations

Liu, Yi, Yasunori Deguchi, Rui Tian, et al.. (2019). Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion. Cancer Research. 79(5). 954–969. 45 indexed citations

Xie, Victoria K., Zhiwei Li, Yongmin Yan, et al.. (2017). DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression. Clinical Cancer Research. 23(18). 5585–5597. 36 indexed citations

Guo, Kun, Jiujie Cui, Ming Quan, et al.. (2016). The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer. Clinical Cancer Research. 23(3). 687–696. 67 indexed citations

10.

Yan, Yongmin, Zhiwei Li, Xiangyu Kong, et al.. (2016). KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis. Cancer Research. 76(8). 2419–2431. 56 indexed citations

11.

Quan, Ming, Jiujie Cui, Tian Xia, et al.. (2015). Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling. Cancer Research. 75(22). 4778–4789. 44 indexed citations

12.

Sun, Hongcheng, Huamei Tang, Dacheng Xie, et al.. (2015). Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6. Clinical Cancer Research. 22(2). 502–512. 28 indexed citations

13.

Li, Zhiwei, Zhiliang Jia, Yong Gao, et al.. (2014). Activation of Vitamin D Receptor Signaling Downregulates the Expression of Nuclear FOXM1 Protein and Suppresses Pancreatic Cancer Cell Stemness. Clinical Cancer Research. 21(4). 844–853. 49 indexed citations

14.

Cui, Jiujie, Min Shi, Dacheng Xie, et al.. (2014). FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression. Clinical Cancer Research. 20(10). 2595–2606. 197 indexed citations

15.

Shi, Min, Jiujie Cui, Jiawei Du, et al.. (2014). A Novel KLF4/LDHA Signaling Pathway Regulates Aerobic Glycolysis in and Progression of Pancreatic Cancer. Clinical Cancer Research. 20(16). 4370–4380. 156 indexed citations

16.

Huang, Chen, Zhengjun Qiu, Liwei Wang, et al.. (2011). A Novel FoxM1-Caveolin Signaling Pathway Promotes Pancreatic Cancer Invasion and Metastasis. Cancer Research. 72(3). 655–665. 147 indexed citations

17.

Gao, Yong, Zhiliang Jia, Xiangyu Kong, et al.. (2011). Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and Angiogenesis. Cancer Research. 71(15). 5182–5193. 85 indexed citations

18.

Jia, Zhiliang, Yong Gao, Liwei Wang, et al.. (2010). Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity. Cancer Research. 70(3). 1111–1119. 63 indexed citations

19.

Li, Qiang, Nu Zhang, Zhiliang Jia, et al.. (2009). Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression. Cancer Research. 69(8). 3501–3509. 177 indexed citations

20.

Wei, Daoyan, et al.. (2008). Kruppel-like Factor 4 Induces p27Kip1 Expression in and Suppresses the Growth and Metastasis of Human Pancreatic Cancer Cells. Cancer Research. 68(12). 4631–4639. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact